Julie Rathbun | Investor Relations |
Jonathan Drachman | Chief Executive Officer |
Priti Patel | Chief Medical Officer |
Sean Smith | Vice President, Finance |
Mary Kate | Bank of America |
Charles Zhu | Guggenheim Securities |
Ben Burnett | Stifel |
Mara Goldstein | Mizuho Securities |
Good afternoon and thank you for joining us today for the Neoleukin Therapeutics Conference Call. [Operator Instructions] As a reminder, today’s conference is being recorded. I would now like to turn the call over to Julie Rathbun, Communications for Neoleukin Therapeutics. Julie, please go ahead.
Thank you.